Search Results - "Sawa, Hitomi"

Feasibility of trimethoprim/sulfamethoxazole desensitization therapy in hematological diseases by Negishi, Shuto, Miyao, Kotaro, Ohara, Fumiya, Motegi, Kenta, Wakabayashi, Hiroya, Yokota, Hirofumi, Kuwano, Shihomi, Takeuchi, Yuki, Sawa, Hitomi, Inagaki, Yuichiro, Sawa, Masashi

“…The effectiveness and safety of trimethoprim/sulfamethoxazole (TMP/SMX) desensitization therapy is insufficiently evaluated in hematological diseases. From…”
Get full text

Letermovir Improves the Outcome of Allogenic Stem Cell Transplantation with Anti-Thymocyte Globulin By Reducing Relapse by Negishi, Shuto, Miyao, Kotaro, Ohara, Fumiya, Wakabayashi, Hiroya, Motegi, Kenta, Sawa, Hitomi, Inagaki, Yuichiro, Sawa, Masashi

“…Background: After an allogenic stem cell transplantation (allo-SCT), patients face the risk of infection, and cytomegalovirus (CMV) is a common pathogen…”
Get full text

MO29-1 The present activity and issues of AYA support team for the patients in AYA generation by Inagaki, Yuichiro, Negishi, Shuto, Sawa, Hitomi, Miyao, Kotaro, Takahashi, Kosuke, Arima, Junko, Sawa, Masashi

Get full text

P38-1 The clinical result of cancer multi-gene panel testing in Anjo Kosei Hospital by Inagaki, Yuichiro, Negishi, Syuto, Yokota, Hirofumi, Sawa, Hitomi, Miyao, Kotaro, Takahashi, Kosuke, Arima, Junko, Sawa, Masashi

Get full text

Efficacy and Safety of Reduced-Dose Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) in Patients over 80 with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) by Miyao, Kotaro, Wakayama, Tomoyoshi, Ozaki, Somi, Numata, Masaya, Negishi, Shuto, Ohara, Fumiya, Motegi, Kenta, Wakabayashi, Hiroya, Sawa, Hitomi, Sakai, Toshiyasu, Inagaki, Yuichiro, Sawa, Masashi

“…Background: The standard treatment for newly diagnosed DLBCL has been R-CHOP for many years. Recently, Pola-R-CHP using polatuzumab vedotin has been reported…”
Get full text

P25-9 The clinical courses of solid tumors with microsatellite instability-high (MSI-H) by Inagaki, Yuichiro, Ohara, Fumiya, Yokota, Hirofumi, Takeuchi, Yuki, Sawa, Hitomi, Miyao, Kotaro, Takashi, Seki, Arima, Junko, Yoneyama, Eiji, Sawa, Masashi

Get full text

An unexpected but successful pregnancy for young lady with CML by Yokota, Hirofumi, Inagaki, Yuichiro, Takeuchi, Yuki, Kuwano, Shihomi, Sawa, Hitomi, Imai, Kanae, Kato, Tomonori, Sawa, Masashi

Get full text

P1-108An unexpected but successful pregnancy for young lady with CML by Yokota, Hirofumi, Inagaki, Yuichiro, Takeuchi, Yuki, Kuwano, Shihomi, Sawa, Hitomi, Imai, Kanae, Kato, Tomonori, Sawa, Masashi

“…Abstract Background The prognosis of CML has dramatically improved with the introduction of imatinib. Patients diagnosed in chronic phase can live almost as…”
Get full text

Exploring the Safety and Efficacy of Upfront Autologous Stem Cell Transplantation with LEED Preconditioning for Primary Central Nervous System Lymphoma by Yokota, Hirofumi, Miyao, Kotaro, Ohara, Fumiya, Motegi, Kenta, Wakabayashi, Hiroya, Takeuchi, Yuki, Kuwano, Shihomi, Sawa, Hitomi, Inagaki, Yuichiro, Sawa, Masashi

“…Introduction The prognosis of primary central nervous system lymphoma (PCNSL) has improved with the introduction of high-dose methotrexate (HD-MTX)-based…”
Get full text

The optimal treatment strategy in primary central nervous system lymphoma, 32 cases in our hospital by Takeuchi, Yuki, Inagaki, Yuichiro, Yokota, Hirofumi, Sawa, Hitomi, Taniyama, Shihomi, Imai, Kanae, Kato, Tomonori, Arima, Junko, Yoneyama, Eiji, Sawa, Masashi

Get full text

O2-13-2The optimal treatment strategy in primary central nervous system lymphoma, 32 cases in our hospital by Takeuchi, Yuki, Inagaki, Yuichiro, Yokota, Hirofumi, Sawa, Hitomi, Taniyama, Shihomi, Imai, Kanae, Kato, Tomonori, Arima, Junko, Yoneyama, Eiji, Sawa, Masashi

Get full text

The therapeutic effect and immune-related adverse event of nivolmab in Anjo Kosei Hospital by Inagaki, Yuichiro, Yokota, Hirofumi, Takeuchi, Yuki, Sawa, Hitomi, Seki, Takashi, Akita, Hidetoshi, Takeuchi, Mamiko, Mitsuya, Shoji, Arima, Junko, Yoneyama, Eiji, Sawa, Masashi

Get full text

P2-189The therapeutic effect and immune-related adverse event of nivolmab in Anjo Kosei Hospital by Inagaki, Yuichiro, Yokota, Hirofumi, Takeuchi, Yuki, Sawa, Hitomi, Seki, Takashi, Akita, Hidetoshi, Takeuchi, Mamiko, Mitsuya, Shoji, Arima, Junko, Yoneyama, Eiji, Sawa, Masashi

“…Abstract Background Nivolmab is approved as a novel immunocheckpoint inhibitor and peculiar immune-related adverse events (irAE) including interstitial lung…”
Get full text

Low Dose ATG-T for cGVHD Prophylaxis, HLA Matched R/UR-PBSCT 68 Cases by Takeuchi, Yuki, Yokota, Hirofumi, Kuwano, Shihomi, Sawa, Hitomi, Miyao, Kotaro, Inagaki, Yuichiro, Sawa, Masashi

Get full text

Clinical Benefit of Low-Dose Antithymocyte Globulin-Thymoglobulin as Graft-versus-Host Disease Prophylaxis in Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation from HLA-Identical Donors by Takeuchi, Yuki, Miyao, Kotaro, Negishi, Shuto, Ohara, Fumiya, Motegi, Kenta, Wakabayashi, Hiroya, Yokota, Hirofumi, Kuwano, Shihomi, Sawa, Hitomi, Inagaki, Yuichiro, Sawa, Masashi

“…•We retrospectively analyzed the efficacy and safety of peripheral blood stem cell transplantation (PBSCT) with low-dose antithymocyte globulin (ATG)…”
Get full text